Cargando…

Nab-paclitaxel as First Line Treatment for NSCLC in Elderly Patients More Than 75 Years Old

Introduction: Lung cancer is still the leading cause of cancer among cancer patients. Although there are novel therapies as second line treatment for NSCLC, there is an issue for elderly patients. Patients and Methods: We collected retrospectively data from 60 patients >75 years of age. Thirty of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zarogoulidis, Paul, Huang, Haidong, Bai, Chong, Petridis, Dimitris, Papadopoulou, Susana, Faniadou, Eleni, Eleftheriadou, Ellada, Trakada, Georgia, Cristoforos, Kosmidis, Rapti, Aggeliki, Yarmus, Lonny, Kopman, David-Feller, Man, Yan-Gao, Hohenforst-Schmidt, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535723/ https://www.ncbi.nlm.nih.gov/pubmed/28775787 http://dx.doi.org/10.7150/jca.19463

Ejemplares similares

Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach
por: Petridis, Dimitris, et al.
Publicado: (2014)

Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Re-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case series
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

“Liquid elbows” due to afatinib administration
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Immunotherapy “Shock” a case series of PD-L1 100% and pembrolizumab first-line treatment
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Reduction of exercise capacity in sarcoidosis in relation to disease severity
por: Kallianos, Anastasios, et al.
Publicado: (2015)

Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2014)

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
por: Blais, Normand, et al.
Publicado: (2014)

Erratum: Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
Publicado: (2014)

New dilemmas in small-cell lung cancer TNM clinical staging
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
por: Katsurada, Naoko, et al.
Publicado: (2020)

A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Progressive dyspnea due to pulmonary carcinoid tumorlets
por: Kallianos, Anastasios, et al.
Publicado: (2017)

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy
por: Thomas, Michael, et al.
Publicado: (2017)

A Multifactoral Analysis of 1452 Patients for Smoking Sensation. An Outpatient Lab Experience
por: Tsiouda, Theodora, et al.
Publicado: (2014)

Improving lung cancer screening: An equitable strategy through a tobacco treatment clinic
por: Galiatsatos, Panagis, et al.
Publicado: (2021)

TRACHEOSTOMY AND COVID-19 ARDS: ONE ACADEMIC CENTER’S EXPERIENCE
por: Kapp, Chris, et al.
Publicado: (2020)

Impact of Video Game Cross-Training on Learning Bronchoscopy. A Pilot Randomized Controlled Trial
por: Mallow, Christopher, et al.
Publicado: (2020)

Lung Cancer and Eye Metastases
por: Lampaki, Sofia, et al.
Publicado: (2014)

nab-Paclitaxel for the treatment of pancreatic cancer
por: Kim, George
Publicado: (2017)

Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
por: Kokubu, Hiraku, et al.
Publicado: (2023)

Modification of Apremilast from Pills to Aerosol a Future Concept
por: Zarogoulidis, Paul, et al.
Publicado: (2021)

Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis
por: Zarogoulidis, Paul, et al.
Publicado: (2013)

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC
por: Langer, Corey J., et al.
Publicado: (2018)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021)

Interleukin-7 and Interleukin-15 for Cancer
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Radiation Exposure of Patients by Cone Beam CT during Endobronchial Navigation - A Phantom Study
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2014)

Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer
por: Wan, Rui, et al.
Publicado: (2023)

Clinicopathological features and relation between anaplastic lymphoma kinase (ALK) mutation and histological subtype of lung adenocarcinoma in Eastern European Caucasian population
por: Zaric, Bojan, et al.
Publicado: (2016)

Immunotherapy and Chemotherapy Versus Sleep Disturbances for NSCLC Patients
por: Zarogoulidis, Paul, et al.
Publicado: (2023)

Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
por: de Leon, Maria C.B., et al.
Publicado: (2013)

nab-Paclitaxel dose and schedule in breast cancer
por: Martín, Miguel
Publicado: (2015)

Neoadjuvant nab-paclitaxel in the treatment of breast cancer
por: Ueno, Naoto T., et al.
Publicado: (2016)

Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab−Paclitaxel and Maintenance Monotherapy with nab−Paclitaxel: Two Case Reports
por: Araya, Tomoyuki, et al.
Publicado: (2020)

Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today
por: Kallianos, Anastasios, et al.
Publicado: (2013)

Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
por: Zarogoulidis, Paul, et al.
Publicado: (2022)

First-Line Treatment with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel for a Thymic Carcinoma: A Case Report
por: Funaishi, Kunihiko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gu535b5e7l5vu2skc5mjj56aij